E-LIB Suche - Ergebnisse für: Ribero S

1

Insights on different erythroderma features in Sezary syndr..:

Roccuzzo, G. ; Fava, P. ; Ribero, S..
EJC Skin Cancer. 2 (2024) - p. 100066 , 2024

Link: https://doi.org/10.1016/..

2

Real-world outcomes of adjuvant therapy in melanoma: an Ita..:

Roccuzzo, G. ; Carpentieri, G. ; Bongiovanni, E....
EJC Skin Cancer. 2 (2024) - p. 100187 , 2024

Link: https://doi.org/10.1016/..

3

Clinicopathological definition, management and prognostic v..:

Avallone, G. ; Roccuzzo, G. ; Pileri, A....
Journal of the European Academy of Dermatology and Venereology. , 2024

Link: https://doi.org/10.1111/..

4

Estudio longitudinal de los diferentes patrones de progresi..:

Tejera-Vaquerizo, A. ; Cañueto, J. ; Gómez-Tomás, A....
Actas Dermo-Sifiliográficas. 115 (2024) 7 - p. 670-678 , 2024

Link: https://doi.org/10.1016/..

5

[Translated article] Longitudinal Study of Different Progre..:

Tejera-Vaquerizo, A. ; Cañueto, J. ; Gómez-Tomás, A....
Actas Dermo-Sifiliográficas. 115 (2024) 7 - p. T670-T678 , 2024

Link: https://doi.org/10.1016/..

6

Predictors of recurrence and progression in poorly differen..:

Roccuzzo, G. ; Orlando, G. ; Rumore, M.R....
EJC Skin Cancer. 2 (2024) - p. 100242 , 2024

Link: https://doi.org/10.1016/..

7

More than one shade of pink as a marker of early amelanotic..:

Pizzichetta, M. A. ; Corsetti, P. ; Stanganelli, I....
The Journal of Dermatology. 51 (2024) 7 - p. 999-1003 , 2024

Link: https://doi.org/10.1111/..

8

Circulating tumor DNA: a promising biomarker in stage III B..:

Roccuzzo, G. ; Bongiovanni, E. ; Marchisio, S....
EJC Skin Cancer. 2 (2024) - p. 100120 , 2024

Link: https://doi.org/10.1016/..

9

Updates on CTCL diagnostic and therapeutic trends amidst th..:

Roccuzzo, G. ; Macagno, N. ; Sarda, C....
EJC Skin Cancer. 2 (2024) - p. 100069 , 2024

Link: https://doi.org/10.1016/..

10

Upadacitinib improves symptoms of concomitant allergic rhin..:

Gargiulo, L. ; Ibba, L. ; Piscazzi, F....
Journal of the European Academy of Dermatology and Venereology. , 2024

Link: https://doi.org/10.1111/..

11

Drug survival, effectiveness and safety of ixekizumab for m..:

Mastorino, L. ; Dapavo, P. ; Burzi, L....
Journal of the European Academy of Dermatology and Venereology. 38 (2023) 3 - p. 568-575 , 2023

Link: https://doi.org/10.1111/..

12

Efficacy of tralokinumab after failure with upadacitinib an..:

Mastorino, L. ; Gelato, F. ; Quaglino, P...
Journal of Dermatological Treatment. 34 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

13

USING PARTICIPATORY DESIGN TO CREATE ADOLESCENT-CENTERED CO..:

Geppert, AA ; Moss, E ; Burrell, Q...
Contraception. 127 (2023) - p. 110245 , 2023

Link: https://doi.org/10.1016/..

14

'Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab fai..:

Mastorino, L. ; Ortoncelli, M. ; Dapavo, P...
Journal of the European Academy of Dermatology and Venereology. 38 (2023) 2 - p. , 2023

Link: https://doi.org/10.1111/..

15

Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab fail..:

Mastorino, L. ; Susca, S. ; Cariti, C....
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 9 - p. 1848-1853 , 2023

Link: https://doi.org/10.1111/..